Amtolmetin Guacyl versus Piroxicam in Patients with Osteoarthritis

Author： Montrone F   Santandrea S   Caruso I   Gerli R   Cesarotti MEF   Frediani PV   Bassani R  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.28, Iss.2, 2000-03, pp. : 91-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The mechanism of action of amtolmetin guacyl, a new gastroprotective nonsteroidal anti-inflammatory drug

By Tubaro E.   Belogi L.   Mezzadri C.M.  

European Journal of Pharmacology, Vol. 387, Iss. 2, 2000-01 ,pp. : 233-244

Elsevier

Access to resources Recommend Favorite

Impact on the bowel of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug

By Tubaro E.   Belogi L.   Mezzadri C.M.   Bettelli E.  

European Journal of Pharmacology, Vol. 467, Iss. 1, 2003-04 ,pp. : 173-183

Elsevier

Access to resources Recommend Favorite

Modelling Therapeutic Strategies in the Treatment of Osteoarthritis: An Economic Evaluation of Meloxicam Versus Diclofenac and Piroxicam

By Tavakoli M.  

PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. : 443-454

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK

By Adis International Limited  

PharmacoEconomics, Vol. 23, Iss. 7, 2005-01 ,pp. : 743-743

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Celecoxib versus Naproxen in Patients with Osteoarthritis of the Knee: a Randomized, Double-blind, Double-dummy Trial

By Essex MN   Bhadra P   Sands GH  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1357-1370

Field House Publishing

Access to resources Recommend Favorite